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Lifestyle measures for treating hypertension
Wilbert S. Aronow
Hypertension needs to be adequately controlled to reduce cardiovas-
cular events and mortality [1–4]. Lifestyle modification should be used to 
prevent mild hypertension and to reduce the dose levels of drugs need-
ed to control hypertension. Weight reduction, consuming a diet rich in 
fruits, vegetables, and low-fat dairy products with less saturated fat and 
total fat, sodium reduction to not exceed 1.5 g daily, smoking cessation, 
regular aerobic physical activity, avoidance of excessive alcohol intake, 
avoidance of excessive caffeine, and avoidance of drugs which can in-
crease blood pressure, including nonsteroidal anti-inflammatory drugs, 
glucocorticoids, and sympathomimetics, are recommended [4, 5]. Imple-
menting a national salt reduction program is a simple and cost-effective 
way of improving public health [6, 7].
Long-term observational follow-up was performed in 744 persons in 
the first phase of the Trials of Hypertension Prevention (TOHP I) (10 years 
after its end) and in 2,382 persons in TOHP II (5 years after its end), 
in which persons with prehypertension were randomized to sodium re-
duction or to a usual diet (25–35% greater sodium intake) [8]. In these 
studies, sodium reduction reduced cardiovascular events by 25%. At 
31-month follow-up of 1,981 Taiwanese veterans living in a retirement 
home, older men randomized to a  potassium-enriched diet with 50% 
less sodium had a 41% decrease in cardiovascular mortality compared 
with those randomized to a regular salt diet [9].
At 14.8-year follow-up of 12,267 adults in the Third National Health 
and Nutrition Examination Survey, a higher sodium intake was associated 
with a 20% increase in all-cause mortality per 1,000 mg of sodium intake 
per day, whereas a higher potassium intake was associated with a 20% re-
duction in mortality per 1,000 mg of potassium intake per day [10]. For the 
sodium-potassium ratio, compared with the lowest quartile, the highest 
quartile increased all-cause mortality by 46%, cardiovascular mortality by 
46%, and ischemic heart disease mortality by 215% [10]. A meta-analysis 
of 56 randomized controlled trials showed a mean blood pressure reduc-
tion of 3.7/0.9 mm Hg for a 100 mmol/day reduction in sodium excretion 
[11]. Current guidelines suggest no more than 2,300 mg of sodium daily in 
the general population and no more than 1,500 mg of sodium daily in 
older persons, in blacks, and in persons with hypertension, diabetes mel-
litus, chronic kidney disease, or heart failure [12].
A one-third decrease in dietary sodium intake in Finland was asso-
ciated with a decrease in blood pressure and a 75% to 80% decrease 
in both coronary heart disease and stroke mortality [13]. Data from the 
Health Survey for England included 9183 persons in 2003, 8762 per-
sons in 2006, 8974 persons in 2008, and 4753 persons in 2011 [14]. 
From 2003 to 2011, salt intake measured by 24-hour urinary sodium 
Wilbert S. Aronow
1242 Arch Med Sci 5, August / 2017
was 1.9 g less per day, blood pressure in persons 
not taking antihypertensive medication was lower 
by 2.7/1.1 mm Hg, mortality from stroke was 42% 
lower, and mortality from ischemic heart disease 
was 40% lower [14]. A meta-analysis of 34 trials 
including 3230 persons showed that sodium re-
duction reduced blood pressure by 5.39/2.82 mm 
Hg in persons with hypertension [15]. A modeling 
study demonstrated that 1.65 million cardiovas-
cular deaths in 2010 were caused by sodium con-
sumption above a reference level of 2 g/day [16].
Reduction of dietary sodium intake by lowering 
sodium content in processed food and by not add-
ing salt to food would lead to a lower blood pres-
sure and to a  decrease in cardiovascular events 
and mortality. A national salt reduction program is 
one of the simplest and most cost-effective ways 
of improving public health.
Other lifestyle measures in treating prehyperten-
sion and hypertension include weight control, smok-
ing cessation, aerobic physical activity, reduction in 
dietary fat and cholesterol, adequate dietary potas-
sium, calcium, and magnesium intake, avoidance 
of excessive alcohol intake (no more than 1 ounce 
daily in men and half an ounce daily in women and 
light-weight men), avoidance of excessive caffeine, 
and avoidance of drugs which increase blood pres-
sure such as nonsteroidal anti-inflammatory drugs, 
sympathomimetics, glucocorticoids, etc. [4, 5].
The body mass index should be maintained be-
tween 18.5 and 24.9 kg/m2 [4, 5]. A meta-analysis 
of 25 randomized, controlled trials including 4874 
persons showed that a weight reduction of 5.1 kg 
by means of reduction of caloric intake, increased 
physical activity, or both, reduced the blood pres-
sure by 4.44/3.57 mm Hg [17].
The Dietary Approaches to Stop Hypertension 
(DASH) diet is rich in fruits, vegetables, and low-
fat dairy products with a decreased content of sat-
urated and total fat [18, 19]. In 459 persons with 
blood pressures of <160/80–95 mm Hg, compared 
with a control diet, the DASH diet reduced blood 
pressure by 5.5/3.0 mm Hg more than the control 
diet [18]. In 412 persons, compared with a  con-
trol diet with a  high sodium content, the DASH 
diet with a  low sodium content reduced systolic 
blood pressure by 11.5 mm Hg in persons with hy-
pertension and by 7.1 mm Hg in persons without 
hypertension [19].
A  meta-analysis of 33 randomized controlled 
trials including 2609 persons in which potassium 
supplementation was the only difference between 
the intervention and control groups demonstrated 
that potassium supplementation in the diet re-
duced blood pressure by 3.11/1/97 mm Hg [20]. 
Another meta-analysis of 22 randomized con-
trolled trials including 1606 persons showed that 
increased potassium intake in the diet reduced 
blood pressure by 3.49/1.96 mm Hg [21]. A me-
ta-analysis of 11 cohort studies including 127,038 
persons showed that increased potassium in the 
diet reduced stroke by 24%, insignificantly re-
duced cardiovascular disease by 12%, and did not 
affect the incidence of coronary heart disease [21].
A  meta-analysis of 40 randomized controlled 
trials including 2492 persons showed that calci-
um supplementation in the diet by a mean daily 
dose of 1200 mg reduced blood pressure by 1.86/ 
0.99 mm Hg [22]. Magnesium supplementation 
in the diet has also been shown to cause a small 
reduction in blood pressure [23]. A  meta-analy-
sis of 40 randomized controlled trials including 
3,277 persons showed that partially replacing di-
etary carbohydrate with increased dietary protein 
reduced blood pressure by 2.27/1.26 mm Hg for 
vegetable protein and 2.54/0.95 mm Hg for ani-
mal protein [24]. A meta-analysis of 25 random-
ized controlled trials showed that increased intake 
of dietary fiber may reduce blood pressure in per-
sons with hypertension [25]. A  meta-analysis of 
7 randomized controlled trials comprising 9 treat-
ment arms and including 587 patients showed 
that the dietary flavonol quercetin reduced blood 
pressure by 3.04/2.63 mm Hg [26]. With quer-
cetin doses of ≥ 500 mg/day, quercetin reduced 
blood pressure by 4.45/2.98 mm Hg. There was 
no significant effect for blood pressure reduction 
for doses of quercetin less than 500 mg/day [26].
A  meta-analysis of 54 randomized controlled 
trials including 2419 persons showed that aer-
obic exercise reduced blood pressure by 3.84/ 
2.58 mm Hg [27]. Aerobic exercise reduced blood 
pressure in persons with and without hypertension 
and in overweight and in normal-weight persons 
[27]. A meta-analysis of 93 trials involving 105 en-
durance exercise trials, 29 dynamic resistance exer-
cise trials, 14 combined exercise trials, and 5 isomet-
ric resistance exercise trials including 5223 persons 
(3401 exercise participants and 1822 control par-
ticipants) showed that endurance exercise reduced 
blood pressure by 3.5/2.5 mm Hg, dynamic resistance 
exercise reduced blood pressure by 1.8/3.2 mm Hg, 
and isometric resistance reduced blood pressure by 
10.9/6.2 mm Hg [28]. Combined training reduced 
diastolic blood pressure by 2.2 mm Hg. Endurance 
exercise reduced systolic blood pressure more in per-
sons with hypertension (8.3 mm Hg) than in prehy-
pertensive persons (2.1 mm Hg) [28].
A  meta-analysis of 15 randomized controlled 
trials including 2234 persons showed that alcohol 
reduction reduced blood pressure by 3.31/2.04 mm 
Hg [29]. Alcohol reduction is recommended for the 
prevention and treatment of hypertension [4, 5, 29].
Sodium reduction, weight loss, increased 
physical activity, and limited alcohol intake are 
established lifestyle measures to reduce blood 
pressure. The DASH diet also reduces blood pres-
sure. A study was performed in 4 clinical centers 
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which included 810 persons, mean age 50 years 
(62% women and 34% blacks) with above optimal 
blood pressure not taking antihypertensive drugs 
[30]. In this study, 268 persons were randomized 
to established lifestyle measures, 269 persons 
to established lifestyle measures plus the DASH 
diet, and 273 persons to an advice control group. 
After subtracting the reduction in blood pressure 
from the advice group, the mean net reduction in 
systolic blood pressure was 3.7 mm Hg with es-
tablished lifestyle measures and 4.3 mm Hg with 
established lifestyle measures plus the DASH diet. 
At 6-month follow-up, the prevalence of a systolic 
blood pressure below 120/80 mm Hg was 19% in 
the advice group, 30% in the established lifestyle 
measures group, and 35% in the established life-
style measures plus DASH diet group [30].
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